{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:30:48Z","timestamp":1789205448392,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jdiacomp.2017.04.005","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T06:46:15Z","timestamp":1491461175000},"page":"929-932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-7262","authenticated-orcid":false,"given":"Ray","family":"El Boustany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Taveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Chollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Velho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3321-0819","authenticated-orcid":false,"given":"Lise","family":"Bankir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Alhenc-Gelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Bouby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcna.2012.10.001","article-title":"Epidemiology of diabetic kidney disease","volume":"97","author":"Reutens","year":"2013","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrneph.2013.22","article-title":"Vasopressin: a novel target for the prevention and retardation of kidney disease?","volume":"9","author":"Bankir","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0015","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ijo.2012.88","article-title":"Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmo diet and cancer study cardiovascular cohort","volume":"37","author":"Enhorning","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.2009.397","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort","volume":"77","author":"Meijer","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000439061","article-title":"Plasma copeptin and decline in renal function in a cohort from the community: the prospective D.E.S.I.R. Study","volume":"42","author":"Roussel","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0030","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00125-013-2922-0","article-title":"Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33)","volume":"56","author":"Boertien","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0035","first-page":"9730","article-title":"Serum copeptin as a new biomarker in the early diagnosis of decline in renal function of type 2 diabetes mellitus patients","volume":"8","author":"Hu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0040","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jdiacomp.2015.07.006","article-title":"Association between copeptin and declining glomerular filtration rate in people with newly diagnosed diabetes. The Skaraborg diabetes register","volume":"29","author":"Pikkemaat","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0045","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.2337\/dc13-0683","article-title":"Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria","volume":"36","author":"Velho","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0050","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jdiacomp.2016.07.017","article-title":"Serum levels of copeptin are associated with type 2 diabetes and diabetic complications in Chinese population","volume":"30","author":"Zhu","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0055","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jdiacomp.2016.04.012","article-title":"Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes","volume":"30","author":"Bjornstad","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0060","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2337\/dc16-1003","article-title":"Plasma copeptin, kidney outcomes, ischemic heart disease, and all-cause mortality in people with long-standing type 1 diabetes","volume":"39","author":"Velho","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ndt\/18.3.497","article-title":"Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system","volume":"18","author":"Bardoux","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0070","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V76842","article-title":"Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action","volume":"7","author":"Bouby","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0075","first-page":"F973","article-title":"Effect of water intake on the progression of chronic renal failure in the 5\/6 nephrectomized rat","volume":"258","author":"Bouby","year":"1990","journal-title":"Am J Phys"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0080","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/ndt\/gfg277","article-title":"Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats","volume":"18","author":"Bardoux","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0085","doi-asserted-by":"crossref","first-page":"R1840","DOI":"10.1152\/ajpregu.00457.2007","article-title":"Modulation of single-nephron GFR in the db\/db mouse model of type 2 diabetes mellitus. II. Effects of renal mass reduction","volume":"294","author":"Levine","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0090","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.V451091","article-title":"Is the process of urinary urea concentration responsible for a high glomerular filtration rate?","volume":"4","author":"Bankir","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0303-7207(84)90111-4","article-title":"Reduction in hepatic but not in renal and vascular vasopressin receptor number in hyperinsulinemic mice and rats","volume":"38","author":"Cantau","year":"1984","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-2001-16345","article-title":"Expression of arginine vasopressin and vasopressin V1a receptor mRNA in diabetic (db\/db) mice","volume":"109","author":"Morita","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00125-015-3496-9","article-title":"Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats","volume":"58","author":"Taveau","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2017.04.005_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000363300","article-title":"Recent advances in animal models of diabetic nephropathy","volume":"126","author":"Betz","year":"2014","journal-title":"Nephron Exp Nephrol"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872717300417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872717300417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T07:24:31Z","timestamp":1657351471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872717300417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1056872717300417"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.04.005","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}